HAP Trading’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

HAP Trading’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Hold	0	–	–	–	2605
2022 Q4	–	Hold	0	–	–	–	2799
2022 Q3	–	Hold	0	–	–	–	3073
2022 Q2	–	Hold	0	–	–	–	3469
2022 Q1	–	Hold	0	–	–	–	3975
2021 Q4	–	Sell	-61,523	Closed	-$382K	–	3935
2021 Q3	$469K	Buy	61,523 +23,471	+62%	+$199K	0.03%	700
2021 Q2	$369K	Sell	38,052 -16,406	-30%	-$131K	0.02%	754
2021 Q1	$450K	Buy	+54,458	New	+$575K	0.05%	521
2020 Q4	–	Hold	0	–	–	–	3306
2020 Q3	–	Hold	0	–	–	–	2716
2020 Q2	–	Hold	0	–	–	–	2562
2015 Q4	–	Hold	0	–	–	–	1435
2015 Q3	–	Hold	0	–	–	–	1502

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return